FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

KIMMEL ROGER H 		2. Issuer Name and Ticker or Trading Symbol

Endo International plc [ ENDP ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O ROTHSCHILD INC., 1251 AVENUE OF THE AMERICAS 		3. Date of Earliest Transaction (MM/DD/YYYY)

11/15/2017
(Street)

NEW YORK, NY 10020
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares   11/15/2017     S    5134   D $6.90   (1) 138939   (2) D    
Ordinary Shares   11/15/2017     S    4000   D $6.90   (3) 136140   (4) I   In Trust  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.63 to $7.10, inclusive. Mr. Kimmel undertakes to provide to Endo International plc, any security holder of Endo International plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of ordinary shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
(2)  This number represents ordinary shares, of which 48,362 have been deferred under Endo International plc's directors deferred compensation plan.
(3)  The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.63 to $7.09, inclusive. Mr. Kimmel undertakes to provide to Endo International plc, any security holder of Endo International plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of ordinary shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
(4)  This number represents ordinary shares indirectly held by Mr. Kimmel. These ordinary shares are held in trusts for which Mr. Kimmel serves as trustee and as to which shares Mr. Kimmel holds either sole or shared power of disposition and vote.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
KIMMEL ROGER H
C/O ROTHSCHILD INC.
1251 AVENUE OF THE AMERICAS
NEW YORK, NY 10020 		X



Signatures
/s/ Matthew J. Maletta, by power of attorney 11/17/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Endo (NASDAQ:ENDP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Endo Charts.
Endo (NASDAQ:ENDP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Endo Charts.